Arcus Biosciences, Inc.

https://arcusbio.com/
Tags:BiopharmaBioTechDrug
Biotechnology company developing cancer immunotherapies targeting the adenosine and other oncology pathways
Location: United States, Hayward
Total raised: $177M

Investors 4

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
13.11.2017Series C$107MGVArcus Bios...
01.09.2016Series B$70MGVArcus Bios...

Mentions in press and media 6

DateTitleDescriptionCategoryAuthorSource
27.05.2019NYSE chang...“We are providing an improve...--medcitynew...
20.02.2018Term Sheet...IT’S ALL RITE Good morning,...--fortune.co...
13.11.2017Arcus Bios...Additional therapies are neede...--medcitynew...
13.11.2017Arcus Bios...HAYWARD, Calif.–(BUSINESS WI...--aislingcap...
05.09.2016Arcus Bios...Taiho Ventures, LLC today anno...--citybizlis...
01.09.2016Arcus Bios...Arcus Biosciences, a Hayward, ...USA-finsmes.co...